Match Document Document Title
8962022 Pharmaceutical compositions comprising an active substance from the substituted benzhydrylpiperazine family  
The present invention is directed to compositions of taste-masked microparticles comprising a substituted benzhydrylpiperazine coated and a taste-masking layer comprising a water-insoluble polymer...
8956650 Intrabuccally rapidly disintegrating tablet and a production method of the tablets  
An intrabuccally rapidly disintegrating tablet which is manufactured by a simple method, has an enough practical hardness and is rapidly disintegrated in the buccal cavity and its production...
8945618 Intrabuccally rapidly disintegrating tablet and a production method of the tablets  
An intrabuccally rapidly disintegrating tablet which is manufactured by a simple method, has an enough practical hardness and is rapidly disintegrated in the buccal cavity and its production...
8927014 Misuse preventative, controlled release formulation  
Disclosed is a misuse preventative, controlled release composition in the form of a multilayered oral dosage form. A first layer contains a plurality of controlled release microparticles having a...
8927013 Misuse preventative, controlled release formulation  
Disclosed is a misuse preventative, controlled release composition in the form of a multilayered oral dosage form. A first layer contains a plurality of controlled release microparticles having a...
8927017 Pharmaceutical preparation containing gabapentin  
A method for preparing a gabapentin granulate comprising melt granulating gabapentin with polyethylene glycol having a melting point comprised between 50 and 80° C.
8920834 Misuse preventative, controlled release formulation  
Disclosed is a misuse preventative, controlled release formulation comprising a core comprising a first layer and a second layer. The core comprises a superabsorbent material (for example,...
8920833 Misuse preventative, controlled release formulation  
Disclosed is a misuse preventative, controlled release formulation comprising a core comprising a superabsorbent material (for example, polycarbophil), a controlled release coat surrounding the...
8911781 Process of manufacture of novel drug delivery system: multilayer tablet composition of thiazolidinedione and biguanides  
A novel patient-convenient, cost effective pharmaceutical composition, comprising of thiazolidinediones and biguanide for controlling hyperglycemia manufactured as multilayer tablet and its...
8877238 Film-coated tablet or granules containing as active ingredient a pyridylpyrimidine compound or a pharmaceutically acceptable salt of this compound  
Film-coated tablet, consisting of a tablet core with a film coating, or granules containing as active ingredient a pyridylpyrimidine compound or a pharmaceutically acceptable salt of this...
8877249 Granular material for dosage forms  
A dosage form for controlled release is produced from a composition comprising a granular material having a mean particle diameter of 150 to 350 micrometers and a compactibility resulting in a...
8877241 Morphine controlled release system  
A composition for controlled release of an opioid from a pharmaceutical composition, the method comprises controlling the release of at least one opioid into an aqueous medium by erosion of at...
8865219 Orodispersible tablets of bitter active principles  
The invention concerns coated granules including (A) at least one amine-containing pharmacological active principle, preferably as an acid addition salt, the pharmacological active principle being...
8846085 Method for production of directly compressible ibuprofen formulations  
A directly tabletable ibuprofen formulation comprising a) 50-99% by weight of crystalline ibuprofen, b) 1-15% by weight of a finely divided excipient with a surface area of at least 100 m2/g, and...
8846084 Controlled release compositions containing zolpidem  
The present invention relates to controlled release compositions of Zolpidem or pharmaceutically acceptable salts thereof adapted to release Zolpidem over a predetermined time period, according to...
8747896 Mucosal bioadhesive slow release carrier for delivering active principles  
A mucosal bioadhesive slow release carrier comprising an active principle and devoid of starch, lactose, which can release the active principal for a duration of longer than 20 hours. This...
8722083 Fenofibrate formulation  
Various fenofibrate compositions include a plurality of first granules having a high bioavailability in vivo, and a plurality of second granules having a low bioavailability in vivo. The first...
8722133 Method for production of orally rapidly disintegrating tablet comprising imidafenacin as active ingredient  
The present invention herein provides an imidafenacin-containing orally rapidly disintegrating tablet which is excellent in the photostability. The present invention comprises the steps of: (A)...
8703191 Controlled-release pharmaceutical tablets  
Controlled-release tablets exhibiting excellent storage stability are achieved by granulating a pharmaceutically active agent with a hydroxyalkylcelluose, blending the resulting granules with an...
8691272 Multilayer tablet  
A multilayer oral dosage form that provides controlled release of an active compound includes a non-erodible core containing a pharmaceutically active compound and/or a nutritionally active...
8691270 Misuse preventative, controlled release formulation  
Disclosed is a misuse preventative, controlled release formulation comprising a core comprising a superabsorbent material (for example, polycarbophil), a controlled release coat surrounding the...
8685447 Misuse preventative, controlled release formulation  
Disclosed is a misuse preventative, controlled release composition in the form of a multilayered oral dosage form. A first layer contains a plurality of controlled release microparticles having a...
8658207 Extended release tablet formulations of flibanserin and method for manufacturing the same  
The present invention provides pharmaceutical release systems comprising an therapeutically effective amount of flibanserin and at least one pharmaceutically acceptable excipient, characterized in...
8637079 Solid preparation comprising alogliptin and pioglitazone  
A solid preparation containing compound (I), wherein the definition of compound (I) is as defined in the description, and pioglitazone, which is useful as a therapeutic drug for diabetes and the...
8617596 Sustained-release tablet production process  
A process is provided for efficiently producing sustained-release tablets having superior sustained-release properties capable of inhibiting the initial elution of a drug and allowing the drug to...
8568767 Dietary fiber composition  
The present invention provides a chewable composition containing granules of water-soluble dietary fiber. The chewable composition has highly agreeable organolpetic properties and is consumable...
8557283 Controlled release formulations of levodopa and uses thereof  
The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a carboxylic acid. Also provided by this invention is...
8551915 Method for production of vinasses-derived product  
The present invention provides a product for agricultural use in the form of granules or pellets, characterized by comprising at least 30% (w/w) of vinasses and/or sludge measured as a dry extract...
8545886 Extended release tablet formulations of flibanserin and method for manufacturing the same  
The invention is directed to a Pharmaceutical extended release system, particularly for oral administration, of a pH-dependent water-soluble active substance, comprising or essentially consisting...
8535716 Methods and composition of extended delivery of water insoluble drugs  
A pharmaceutical composition is provided that includes an active ingredient in the form of a powder or granule, a water soluble high molecular weight excipient and a water insoluble hydrophilic...
8535799 Controlled agglomeration  
A process for the preparation of a particulate material by a controlled agglomeration method, i.e. a method that enables a controlled growth in particle size. The method is especially suitable for...
8512744 Sustained release micropellets and process for producing the same  
Sustained release micropellets showing a stable controlled-release of a drug without being affected by the changes in pH value etc., characterized by being produced by coating core particles with...
8486449 Misuse preventative, controlled release formulation  
Disclosed is a misuse preventative, controlled release composition in the form of a multilayered oral dosage form. A first layer contains a plurality of controlled release microparticles having a...
8486448 Misuse preventative, controlled release formulation  
Disclosed is a misuse preventative, controlled release formulation comprising a core comprising a superabsorbent material (for example, polycarbophil), a controlled release coat surrounding the...
8465776 Granule and orally disintegrating tablet comprising oxycodone  
The present invention relates to granules comprising oxycodone, as well as to orally disintegrating tablets including same and optionally acetaminophen.
8454998 Controlled release formulations of levodopa and uses thereof  
The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a carboxylic acid. Also provided by this invention is...
8377474 Controlled release formulations of levodopa and uses thereof  
The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a carboxylic acid. Also provided by this invention is...
8372225 Machine and method for pharmaceutical and pharmaceutical-like product assembly  
A method and apparatus for assembling a plurality of independently formed solid components is provided thereby forming a single delivery vehicle for a pharmaceutical or pharmaceutical-like...
8372431 Pharmaceutical composition comprising licarbazepine acetate  
A pharmaceutical composition comprising licarbazepine acetate, especially eslicarbazepine acetate, in combination with suitable excipients, in particular a binder, and a disintegrant. Also...
8357396 Intrabuccally rapidly disintegrating tablet and a production method of the tablets  
An intrabuccally rapidly disintegrating tablet which is manufactured by a simple method, has an enough practical hardness and is rapidly disintegrated in the buccal cavity and its production...
8337887 Rapidly disintegrating taste-masked tablet  
The present invention concerns a rapidly disintegrating taste-masked tablet having both hardness and non-friability properties comprising at least one active principle selected from the group of...
8329216 Oxymorphone controlled release formulations  
The invention pertains to a method of relieving pain by administering a controlled release pharmaceutical tablet containing oxymorphone which produces a mean minimum blood plasma level 12 to 24...
8309122 Oxymorphone controlled release formulations  
The invention pertains to a method of relieving pain by administering a controlled release pharmaceutical tablet containing oxymorphone which produces a mean minimum blood plasma level 12 to 24...
8293277 Controlled-release nanoparticulate compositions  
Described are controlled release nanoparticulate formulations comprising a nanoparticulate agent to be administered and a rate-controlling polymer which functions to prolong the release of the...
8268351 Matrix film tablet with controlled release of a natural mixture of conjugated estrogens  
A pharmaceutical matrix film tablet with controlled release of natural mixtures of conjugated estrogens which have been obtained from the urine of pregnant mares.
8226981 Method of preparing a taste-masking oral dosage form  
A method of preparing a taste-masking oral dosage form is provided. The method includes providing a first solution comprising a pharmaceutically active ingredient and a starch, providing a second...
8211466 Mucosal bioadhesive slow release carrier for delivering active principles  
A mucosal bioadhesive slow release carrier comprising an active principle and devoid of starch, lactose, which can release the active principal for a duration of longer than 20 hours. This...
8202456 Method for preparing sustained release tablet  
Herein provided is a method for easily preparing a sustained release tablet which contains an orally administrable medicinal component, while maintaining the uniformity of the content of the...
8197850 Medicine based on anti-hyperglycaemic microcapsules with prolonged release and method for preparing same  
The invention concerns an oral galenic form for prolonged release of anti-hyperglycaemic (metformin) active principles. Said medicine enables to obtain an efficient therapeutic protection over 24...
8193226 Candesartan cilexetil  
Candesartan cilexetil-containing granules which include a sugar alcohol and a binder and which are produced by granulation with an alcoholic granulating liquid. The granules are suitable for...